Top Markets
Coin of the day
Hyperion DeFi, Inc. Hyperion DeFi, Inc.

Hyperion DeFi, Inc.

HYPD
Rank in Stocks #25598
Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a... Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.
Share Price
$3.16
Last synced: 2026-08-20
Market Cap
$47.90M
Change (1 day)
3.95%
Change (1 year)
-48.20%
Country
US
Trade Hyperion DeFi, Inc. (HYPD)

Category

P/S ratio for Hyperion DeFi, Inc. (HYPD)
P/S ratio as of 2026 TTM: 0
According to Hyperion DeFi, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Hyperion DeFi, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
4.13 -
US
5.03 -
US
2.78 -
IE
3.67 -
US
- -
DE